Margaret V Ragni
University of Pittsburgh · University of Pittsburgh Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
9
all conditions, ClinicalTrials.gov
NIH grants tied to them
9
NIH RePORTER
Trial papers
36
PubMed author-name match
Trials
Studies that name Margaret V Ragni as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:24 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04303572 · The Hemophilia Inhibitor Eradication TrialMargaret Ragni · terminated · Hemophilia A With Inhibitor · principal investigator
- Ph3NCT04303559 · The Hemophilia Inhibitor Prevention TrialMargaret Ragni · terminated · Hemophilia A Without Inhibitor · principal investigator
- Ph3NCT02606045 · Minimize Menorrhagia in Women With Von Willebrand DiseaseMargaret Ragni · terminated · Von Willebrand Diseases · principal investigator
- Ph3NCT02196207 · Hemophilia Inhibitor Clinical Trials (INHIBIT) PlatformMargaret Ragni · withdrawn · Severe Hemophilia A · principal investigator
- Ph3NCT01405742 · Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia AUniversity of Pittsburgh · terminated · Severe Hemophilia A · principal investigator
- Ph2NCT00994929 · Efficacy and Safety of IL-11 in DDAVP UnresponsiveUniversity of Pittsburgh · completed · Hemophilia A, Von Willebrand Disease · principal investigator
- Ph2NCT00524225 · IL-11 in Adults With Von Willebrand Disease Undergoing SurgeryMargaret Ragni · terminated · Von Willebrand Disease · principal investigator
- Ph2NCT00524342 · IL-11 in Women With Von Willebrand Disease and Refractory MenorrhagiaMargaret Ragni · completed · Von Willebrand Disease · principal investigator
- Ph2NCT00151125 · Phase II Study of IL-11 (Neumega) in Von Willebrand DiseaseUniversity of Pittsburgh · completed · Von Willebrand Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Training Students in Biomedical Research in HematologyT35HL074708 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2005 to 2021 · $17,192 awarded in 2021Same name and institution; not confirmed by an ID
- Von Willebrand Disease Minimize Menorrhagia (VWDMin) TrialU01HL133815 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2017 to 2021 · $675,147 awarded in 2021Grant number is on one of their registry trials
- Feasibility of the Von Willebrand Disease Minimize TrialU34HL119582 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2013 to 2015 · $213,921 awarded in 2015Same name and institution; not confirmed by an ID
- Feasibility of the Hemophilia INHIBIT TrialU34HL114674 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2012 to 2013 · $338,817 awarded in 2013Same name and institution; not confirmed by an ID
- Hemophilia Adult Prophylaxis StudyR34HL105870 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2011 to 2012 · $350,670 awarded in 2012Grant number is on one of their registry trials
- IMPACT OF HIV ON HEPATITIS C IN HEMOPHILIA (3HS)M01RR000056 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 1996 to 2005 · $2,266 awarded in 2005Same name and institution; not confirmed by an ID
- Impact of HIV on Hepatitis C Infection in HemophiliaR01HL068429 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2001 to 2004 · $207,197 awarded in 2004Same name and institution; not confirmed by an ID
- EPIDEMIOLOGY AND IMMUNOLOGY OF HEMOPHILIA A INHIBITORSR01HL061937 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 1998 to 2001 · $262,335 awarded in 2001Same name and institution; not confirmed by an ID
- STUDY OF HIV-ASSOCIATED MALIGNANCY IN HEMOPHILIACSR01CA050849 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 1989 to 1993 · $445,380 awarded in 1993Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:24 UTC. The ranking covers the 200 most relevant of 36 PubMed records, and a shared surname and initials can bring in a namesake. All 36 on PubMed
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.Nat Genet · 2000802 citationsRCR 16.5
- Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.N Engl J Med · 2017618 citationsRCR 21.4
- 389 citationsRCR 14.8
- Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.N Engl J Med · 2013319 citationsRCR 11.4
- Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy.N Engl J Med · 2017286 citationsRCR 10.8
- Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A.N Engl J Med · 2021212 citationsRCR 12.0
- Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.J Infect Dis · 1994198 citationsRCR 5.1
- Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.Blood · 2012182 citationsRCR 6.3
- 167 citationsRCR 3.3
- 139 citationsRCR 4.9